GRP and posterior cortical atrophy: Our research group first reported that serum ProGRP is a useful biomarker for monitoring clinical course in small‐cell NE PCa and also for assessing the NE environment and prognosis in conventional metastatic and hormone‐resistant PCa.18, 19, 20, 21